Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient MiceFrédérique Dol, Jean‐Marc Herbert, Catherine Cazaubon et al.|Journal of Cardiovascular Pharmacology|2001Cited by 93
Endothelial effects of hemostatic devices for continuous cardioplegia or minimally invasive operationsLouis P. Perrault, Paul M. Vanhoutte, Philippe Menasché et al.|The Annals of Thoracic Surgery|1996Cited by 43
Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular DiseasesSergio Mallart, Stéphane Illiano, Raffaele Ingenito et al.|Journal of Medicinal Chemistry|2021Cited by 29
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated ComorbiditiesMarie‐Laure Ozoux, Philip Janiak, Véronique Briand et al.|Journal of Pharmacology and Experimental Therapeutics|2020Cited by 16
Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal DiseasesSergio Mallart, Stéphane Illiano, Raffaele Ingenito et al.|Journal of Medicinal Chemistry|2025Cited by 1